Home
Products
Other Intermediates
Dotinod Intermediates
Resmetirol GL3196 Intermediate
Suzetrigine(VX548) Intermediate
Lisapram Intermediates
Baloxavir Intermediates
Ponatinib Intermediates
Delafloxacin Intermediates
AZD-5305 Intermediate
AZD-9574 Intermediate
Ivacaftor Intermediates
Larotrectinib Intermediate
Abemaciclib Intermediates
News
About us
Contact us
Home
Products
Other Intermediates
Dotinod Intermediates
Resmetirol GL3196 Intermediate
Suzetrigine(VX548) Intermediate
Lisapram Intermediates
Baloxavir Intermediates
Ponatinib Intermediates
Delafloxacin Intermediates
AZD-5305 Intermediate
AZD-9574 Intermediate
Ivacaftor Intermediates
Larotrectinib Intermediate
Abemaciclib Intermediates
News
About us
Contact us
Home
News
Zhonghan Biomedical Technology (R)-2-(2, 5-difluorophenyl) pyrrolidine preparation method patent was officially authorized
2025-01-15 10:59
Zhonghan (Qihe County) Biomedical Technology Co., Ltd. welcomed the good news! On June 14, 2024, the State Intellectual Property Office officially issued a notice announcing that the company's pat...
The company has been selected as a project for enhancing the innovation capability of technology-based small and medium-sized enterprises in Shandong Province
2025-01-15 10:56
In November 2021, the Science and Technology Department of Shandong Province announced the first batch of approved projects for the 2021 Shandong Province Science and Technology based Small and Me...
The company has passed ISO9001 quality management system certification, taking quality management to a new level
2025-01-15 10:54
In June 2024, the company announced that it had once again successfully passed the ISO9001 quality management system certification, following its certification in 2021. This marks significant achi...